ERAS

Erasca (ERAS)

About Erasca (ERAS)

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$18.80

Daily low

$17.85

Price at open

$18.61

52 Week High

$24.28

52 Week Low

$1.33

Market cap

6.3B

Dividend yield

0.00%

Volume

771,781

Avg. volume

4.4M

P/E ratio

-19.59

Erasca News